Global CD98 Antibody Supply, Demand and Key Producers, 2023-2029
The global CD98 Antibody market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
CD98 Antibody (E-5) is a mouse monoclonal IgG1 ? CD98 antibody, cited in 18 publications, provided at 200 µg/ml. raised against amino acids 230-529 of CD98 of human origin. CD98 Antibody (E-5) is recommended for detection of CD98 of human origin by WB, IP, IF, IHC(P) and ELISA.
This report studies the global CD98 Antibody demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD98 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD98 Antibody that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CD98 Antibody total market, 2018-2029, (USD Million)
Global CD98 Antibody total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CD98 Antibody total market, key domestic companies and share, (USD Million)
Global CD98 Antibody revenue by player and market share 2018-2023, (USD Million)
Global CD98 Antibody total market by Type, CAGR, 2018-2029, (USD Million)
Global CD98 Antibody total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global CD98 Antibody market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Thermo Fisher Scientific, Bioss, Proteintech Group, Aviva Systems Biology, Leading Biology, RayBiotech, ABclonal Technology and OriGene Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD98 Antibody market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CD98 Antibody Market, By Region:
1. How big is the global CD98 Antibody market?
2. What is the demand of the global CD98 Antibody market?
3. What is the year over year growth of the global CD98 Antibody market?
4. What is the total value of the global CD98 Antibody market?
5. Who are the major players in the global CD98 Antibody market?
6. What are the growth factors driving the market demand?
CD98 Antibody (E-5) is a mouse monoclonal IgG1 ? CD98 antibody, cited in 18 publications, provided at 200 µg/ml. raised against amino acids 230-529 of CD98 of human origin. CD98 Antibody (E-5) is recommended for detection of CD98 of human origin by WB, IP, IF, IHC(P) and ELISA.
This report studies the global CD98 Antibody demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD98 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD98 Antibody that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CD98 Antibody total market, 2018-2029, (USD Million)
Global CD98 Antibody total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CD98 Antibody total market, key domestic companies and share, (USD Million)
Global CD98 Antibody revenue by player and market share 2018-2023, (USD Million)
Global CD98 Antibody total market by Type, CAGR, 2018-2029, (USD Million)
Global CD98 Antibody total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global CD98 Antibody market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Thermo Fisher Scientific, Bioss, Proteintech Group, Aviva Systems Biology, Leading Biology, RayBiotech, ABclonal Technology and OriGene Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD98 Antibody market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CD98 Antibody Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal
- Polyclonal
- Immunochemistry (IHC)
- Immunofluorescence (IF)
- Immunoprecipitation (IP)
- Western Blot (WB)
- ELISA
- Others
- Merck
- Thermo Fisher Scientific
- Bioss
- Proteintech Group
- Aviva Systems Biology
- Leading Biology
- RayBiotech
- ABclonal Technology
- OriGene Technologies
- Novus Biologicals
- R&D Systems
- AssayPro
- Abnova Corporation
- Sino Biological
- Biomatik
- CUSABIO Technology
- Affinity Biosciences
- Creative Biolabs
- Jingjie PTM BioLab
- Beijing Solarbio
1. How big is the global CD98 Antibody market?
2. What is the demand of the global CD98 Antibody market?
3. What is the year over year growth of the global CD98 Antibody market?
4. What is the total value of the global CD98 Antibody market?
5. Who are the major players in the global CD98 Antibody market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 CD98 Antibody Introduction
1.2 World CD98 Antibody Market Size & Forecast (2018 & 2022 & 2029)
1.3 World CD98 Antibody Total Market by Region (by Headquarter Location)
1.3.1 World CD98 Antibody Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States CD98 Antibody Market Size (2018-2029)
1.3.3 China CD98 Antibody Market Size (2018-2029)
1.3.4 Europe CD98 Antibody Market Size (2018-2029)
1.3.5 Japan CD98 Antibody Market Size (2018-2029)
1.3.6 South Korea CD98 Antibody Market Size (2018-2029)
1.3.7 ASEAN CD98 Antibody Market Size (2018-2029)
1.3.8 India CD98 Antibody Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD98 Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD98 Antibody Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CD98 Antibody Consumption Value (2018-2029)
2.2 World CD98 Antibody Consumption Value by Region
2.2.1 World CD98 Antibody Consumption Value by Region (2018-2023)
2.2.2 World CD98 Antibody Consumption Value Forecast by Region (2024-2029)
2.3 United States CD98 Antibody Consumption Value (2018-2029)
2.4 China CD98 Antibody Consumption Value (2018-2029)
2.5 Europe CD98 Antibody Consumption Value (2018-2029)
2.6 Japan CD98 Antibody Consumption Value (2018-2029)
2.7 South Korea CD98 Antibody Consumption Value (2018-2029)
2.8 ASEAN CD98 Antibody Consumption Value (2018-2029)
2.9 India CD98 Antibody Consumption Value (2018-2029)
3 WORLD CD98 ANTIBODY COMPANIES COMPETITIVE ANALYSIS
3.1 World CD98 Antibody Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CD98 Antibody Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CD98 Antibody in 2022
3.2.3 Global Concentration Ratios (CR8) for CD98 Antibody in 2022
3.3 CD98 Antibody Company Evaluation Quadrant
3.4 CD98 Antibody Market: Overall Company Footprint Analysis
3.4.1 CD98 Antibody Market: Region Footprint
3.4.2 CD98 Antibody Market: Company Product Type Footprint
3.4.3 CD98 Antibody Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CD98 Antibody Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CD98 Antibody Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: CD98 Antibody Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: CD98 Antibody Consumption Value Comparison
4.2.1 United States VS China: CD98 Antibody Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CD98 Antibody Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based CD98 Antibody Companies and Market Share, 2018-2023
4.3.1 United States Based CD98 Antibody Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CD98 Antibody Revenue, (2018-2023)
4.4 China Based Companies CD98 Antibody Revenue and Market Share, 2018-2023
4.4.1 China Based CD98 Antibody Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CD98 Antibody Revenue, (2018-2023)
4.5 Rest of World Based CD98 Antibody Companies and Market Share, 2018-2023
4.5.1 Rest of World Based CD98 Antibody Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CD98 Antibody Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CD98 Antibody Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal
5.2.2 Polyclonal
5.3 Market Segment by Type
5.3.1 World CD98 Antibody Market Size by Type (2018-2023)
5.3.2 World CD98 Antibody Market Size by Type (2024-2029)
5.3.3 World CD98 Antibody Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CD98 Antibody Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Immunochemistry (IHC)
6.2.2 Immunofluorescence (IF)
6.2.3 Immunoprecipitation (IP)
6.2.4 Western Blot (WB)
6.2.5 Western Blot (WB)
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World CD98 Antibody Market Size by Application (2018-2023)
6.3.2 World CD98 Antibody Market Size by Application (2024-2029)
6.3.3 World CD98 Antibody Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck CD98 Antibody Product and Services
7.1.4 Merck CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Details
7.2.2 Thermo Fisher Scientific Major Business
7.2.3 Thermo Fisher Scientific CD98 Antibody Product and Services
7.2.4 Thermo Fisher Scientific CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.3 Bioss
7.3.1 Bioss Details
7.3.2 Bioss Major Business
7.3.3 Bioss CD98 Antibody Product and Services
7.3.4 Bioss CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Bioss Recent Developments/Updates
7.3.6 Bioss Competitive Strengths & Weaknesses
7.4 Proteintech Group
7.4.1 Proteintech Group Details
7.4.2 Proteintech Group Major Business
7.4.3 Proteintech Group CD98 Antibody Product and Services
7.4.4 Proteintech Group CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Proteintech Group Recent Developments/Updates
7.4.6 Proteintech Group Competitive Strengths & Weaknesses
7.5 Aviva Systems Biology
7.5.1 Aviva Systems Biology Details
7.5.2 Aviva Systems Biology Major Business
7.5.3 Aviva Systems Biology CD98 Antibody Product and Services
7.5.4 Aviva Systems Biology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Aviva Systems Biology Recent Developments/Updates
7.5.6 Aviva Systems Biology Competitive Strengths & Weaknesses
7.6 Leading Biology
7.6.1 Leading Biology Details
7.6.2 Leading Biology Major Business
7.6.3 Leading Biology CD98 Antibody Product and Services
7.6.4 Leading Biology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Leading Biology Recent Developments/Updates
7.6.6 Leading Biology Competitive Strengths & Weaknesses
7.7 RayBiotech
7.7.1 RayBiotech Details
7.7.2 RayBiotech Major Business
7.7.3 RayBiotech CD98 Antibody Product and Services
7.7.4 RayBiotech CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 RayBiotech Recent Developments/Updates
7.7.6 RayBiotech Competitive Strengths & Weaknesses
7.8 ABclonal Technology
7.8.1 ABclonal Technology Details
7.8.2 ABclonal Technology Major Business
7.8.3 ABclonal Technology CD98 Antibody Product and Services
7.8.4 ABclonal Technology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 ABclonal Technology Recent Developments/Updates
7.8.6 ABclonal Technology Competitive Strengths & Weaknesses
7.9 OriGene Technologies
7.9.1 OriGene Technologies Details
7.9.2 OriGene Technologies Major Business
7.9.3 OriGene Technologies CD98 Antibody Product and Services
7.9.4 OriGene Technologies CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 OriGene Technologies Recent Developments/Updates
7.9.6 OriGene Technologies Competitive Strengths & Weaknesses
7.10 Novus Biologicals
7.10.1 Novus Biologicals Details
7.10.2 Novus Biologicals Major Business
7.10.3 Novus Biologicals CD98 Antibody Product and Services
7.10.4 Novus Biologicals CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Novus Biologicals Recent Developments/Updates
7.10.6 Novus Biologicals Competitive Strengths & Weaknesses
7.11 R&D Systems
7.11.1 R&D Systems Details
7.11.2 R&D Systems Major Business
7.11.3 R&D Systems CD98 Antibody Product and Services
7.11.4 R&D Systems CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 R&D Systems Recent Developments/Updates
7.11.6 R&D Systems Competitive Strengths & Weaknesses
7.12 AssayPro
7.12.1 AssayPro Details
7.12.2 AssayPro Major Business
7.12.3 AssayPro CD98 Antibody Product and Services
7.12.4 AssayPro CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 AssayPro Recent Developments/Updates
7.12.6 AssayPro Competitive Strengths & Weaknesses
7.13 Abnova Corporation
7.13.1 Abnova Corporation Details
7.13.2 Abnova Corporation Major Business
7.13.3 Abnova Corporation CD98 Antibody Product and Services
7.13.4 Abnova Corporation CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Abnova Corporation Recent Developments/Updates
7.13.6 Abnova Corporation Competitive Strengths & Weaknesses
7.14 Sino Biological
7.14.1 Sino Biological Details
7.14.2 Sino Biological Major Business
7.14.3 Sino Biological CD98 Antibody Product and Services
7.14.4 Sino Biological CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Sino Biological Recent Developments/Updates
7.14.6 Sino Biological Competitive Strengths & Weaknesses
7.15 Biomatik
7.15.1 Biomatik Details
7.15.2 Biomatik Major Business
7.15.3 Biomatik CD98 Antibody Product and Services
7.15.4 Biomatik CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Biomatik Recent Developments/Updates
7.15.6 Biomatik Competitive Strengths & Weaknesses
7.16 CUSABIO Technology
7.16.1 CUSABIO Technology Details
7.16.2 CUSABIO Technology Major Business
7.16.3 CUSABIO Technology CD98 Antibody Product and Services
7.16.4 CUSABIO Technology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 CUSABIO Technology Recent Developments/Updates
7.16.6 CUSABIO Technology Competitive Strengths & Weaknesses
7.17 Affinity Biosciences
7.17.1 Affinity Biosciences Details
7.17.2 Affinity Biosciences Major Business
7.17.3 Affinity Biosciences CD98 Antibody Product and Services
7.17.4 Affinity Biosciences CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Affinity Biosciences Recent Developments/Updates
7.17.6 Affinity Biosciences Competitive Strengths & Weaknesses
7.18 Creative Biolabs
7.18.1 Creative Biolabs Details
7.18.2 Creative Biolabs Major Business
7.18.3 Creative Biolabs CD98 Antibody Product and Services
7.18.4 Creative Biolabs CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Creative Biolabs Recent Developments/Updates
7.18.6 Creative Biolabs Competitive Strengths & Weaknesses
7.19 Jingjie PTM BioLab
7.19.1 Jingjie PTM BioLab Details
7.19.2 Jingjie PTM BioLab Major Business
7.19.3 Jingjie PTM BioLab CD98 Antibody Product and Services
7.19.4 Jingjie PTM BioLab CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Jingjie PTM BioLab Recent Developments/Updates
7.19.6 Jingjie PTM BioLab Competitive Strengths & Weaknesses
7.20 Beijing Solarbio
7.20.1 Beijing Solarbio Details
7.20.2 Beijing Solarbio Major Business
7.20.3 Beijing Solarbio CD98 Antibody Product and Services
7.20.4 Beijing Solarbio CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Beijing Solarbio Recent Developments/Updates
7.20.6 Beijing Solarbio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CD98 Antibody Industry Chain
8.2 CD98 Antibody Upstream Analysis
8.3 CD98 Antibody Midstream Analysis
8.4 CD98 Antibody Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 CD98 Antibody Introduction
1.2 World CD98 Antibody Market Size & Forecast (2018 & 2022 & 2029)
1.3 World CD98 Antibody Total Market by Region (by Headquarter Location)
1.3.1 World CD98 Antibody Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States CD98 Antibody Market Size (2018-2029)
1.3.3 China CD98 Antibody Market Size (2018-2029)
1.3.4 Europe CD98 Antibody Market Size (2018-2029)
1.3.5 Japan CD98 Antibody Market Size (2018-2029)
1.3.6 South Korea CD98 Antibody Market Size (2018-2029)
1.3.7 ASEAN CD98 Antibody Market Size (2018-2029)
1.3.8 India CD98 Antibody Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD98 Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD98 Antibody Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CD98 Antibody Consumption Value (2018-2029)
2.2 World CD98 Antibody Consumption Value by Region
2.2.1 World CD98 Antibody Consumption Value by Region (2018-2023)
2.2.2 World CD98 Antibody Consumption Value Forecast by Region (2024-2029)
2.3 United States CD98 Antibody Consumption Value (2018-2029)
2.4 China CD98 Antibody Consumption Value (2018-2029)
2.5 Europe CD98 Antibody Consumption Value (2018-2029)
2.6 Japan CD98 Antibody Consumption Value (2018-2029)
2.7 South Korea CD98 Antibody Consumption Value (2018-2029)
2.8 ASEAN CD98 Antibody Consumption Value (2018-2029)
2.9 India CD98 Antibody Consumption Value (2018-2029)
3 WORLD CD98 ANTIBODY COMPANIES COMPETITIVE ANALYSIS
3.1 World CD98 Antibody Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CD98 Antibody Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CD98 Antibody in 2022
3.2.3 Global Concentration Ratios (CR8) for CD98 Antibody in 2022
3.3 CD98 Antibody Company Evaluation Quadrant
3.4 CD98 Antibody Market: Overall Company Footprint Analysis
3.4.1 CD98 Antibody Market: Region Footprint
3.4.2 CD98 Antibody Market: Company Product Type Footprint
3.4.3 CD98 Antibody Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CD98 Antibody Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CD98 Antibody Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: CD98 Antibody Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: CD98 Antibody Consumption Value Comparison
4.2.1 United States VS China: CD98 Antibody Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CD98 Antibody Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based CD98 Antibody Companies and Market Share, 2018-2023
4.3.1 United States Based CD98 Antibody Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CD98 Antibody Revenue, (2018-2023)
4.4 China Based Companies CD98 Antibody Revenue and Market Share, 2018-2023
4.4.1 China Based CD98 Antibody Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CD98 Antibody Revenue, (2018-2023)
4.5 Rest of World Based CD98 Antibody Companies and Market Share, 2018-2023
4.5.1 Rest of World Based CD98 Antibody Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CD98 Antibody Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CD98 Antibody Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal
5.2.2 Polyclonal
5.3 Market Segment by Type
5.3.1 World CD98 Antibody Market Size by Type (2018-2023)
5.3.2 World CD98 Antibody Market Size by Type (2024-2029)
5.3.3 World CD98 Antibody Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CD98 Antibody Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Immunochemistry (IHC)
6.2.2 Immunofluorescence (IF)
6.2.3 Immunoprecipitation (IP)
6.2.4 Western Blot (WB)
6.2.5 Western Blot (WB)
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World CD98 Antibody Market Size by Application (2018-2023)
6.3.2 World CD98 Antibody Market Size by Application (2024-2029)
6.3.3 World CD98 Antibody Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck CD98 Antibody Product and Services
7.1.4 Merck CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Details
7.2.2 Thermo Fisher Scientific Major Business
7.2.3 Thermo Fisher Scientific CD98 Antibody Product and Services
7.2.4 Thermo Fisher Scientific CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.3 Bioss
7.3.1 Bioss Details
7.3.2 Bioss Major Business
7.3.3 Bioss CD98 Antibody Product and Services
7.3.4 Bioss CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Bioss Recent Developments/Updates
7.3.6 Bioss Competitive Strengths & Weaknesses
7.4 Proteintech Group
7.4.1 Proteintech Group Details
7.4.2 Proteintech Group Major Business
7.4.3 Proteintech Group CD98 Antibody Product and Services
7.4.4 Proteintech Group CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Proteintech Group Recent Developments/Updates
7.4.6 Proteintech Group Competitive Strengths & Weaknesses
7.5 Aviva Systems Biology
7.5.1 Aviva Systems Biology Details
7.5.2 Aviva Systems Biology Major Business
7.5.3 Aviva Systems Biology CD98 Antibody Product and Services
7.5.4 Aviva Systems Biology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Aviva Systems Biology Recent Developments/Updates
7.5.6 Aviva Systems Biology Competitive Strengths & Weaknesses
7.6 Leading Biology
7.6.1 Leading Biology Details
7.6.2 Leading Biology Major Business
7.6.3 Leading Biology CD98 Antibody Product and Services
7.6.4 Leading Biology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Leading Biology Recent Developments/Updates
7.6.6 Leading Biology Competitive Strengths & Weaknesses
7.7 RayBiotech
7.7.1 RayBiotech Details
7.7.2 RayBiotech Major Business
7.7.3 RayBiotech CD98 Antibody Product and Services
7.7.4 RayBiotech CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 RayBiotech Recent Developments/Updates
7.7.6 RayBiotech Competitive Strengths & Weaknesses
7.8 ABclonal Technology
7.8.1 ABclonal Technology Details
7.8.2 ABclonal Technology Major Business
7.8.3 ABclonal Technology CD98 Antibody Product and Services
7.8.4 ABclonal Technology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 ABclonal Technology Recent Developments/Updates
7.8.6 ABclonal Technology Competitive Strengths & Weaknesses
7.9 OriGene Technologies
7.9.1 OriGene Technologies Details
7.9.2 OriGene Technologies Major Business
7.9.3 OriGene Technologies CD98 Antibody Product and Services
7.9.4 OriGene Technologies CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 OriGene Technologies Recent Developments/Updates
7.9.6 OriGene Technologies Competitive Strengths & Weaknesses
7.10 Novus Biologicals
7.10.1 Novus Biologicals Details
7.10.2 Novus Biologicals Major Business
7.10.3 Novus Biologicals CD98 Antibody Product and Services
7.10.4 Novus Biologicals CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Novus Biologicals Recent Developments/Updates
7.10.6 Novus Biologicals Competitive Strengths & Weaknesses
7.11 R&D Systems
7.11.1 R&D Systems Details
7.11.2 R&D Systems Major Business
7.11.3 R&D Systems CD98 Antibody Product and Services
7.11.4 R&D Systems CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 R&D Systems Recent Developments/Updates
7.11.6 R&D Systems Competitive Strengths & Weaknesses
7.12 AssayPro
7.12.1 AssayPro Details
7.12.2 AssayPro Major Business
7.12.3 AssayPro CD98 Antibody Product and Services
7.12.4 AssayPro CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 AssayPro Recent Developments/Updates
7.12.6 AssayPro Competitive Strengths & Weaknesses
7.13 Abnova Corporation
7.13.1 Abnova Corporation Details
7.13.2 Abnova Corporation Major Business
7.13.3 Abnova Corporation CD98 Antibody Product and Services
7.13.4 Abnova Corporation CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Abnova Corporation Recent Developments/Updates
7.13.6 Abnova Corporation Competitive Strengths & Weaknesses
7.14 Sino Biological
7.14.1 Sino Biological Details
7.14.2 Sino Biological Major Business
7.14.3 Sino Biological CD98 Antibody Product and Services
7.14.4 Sino Biological CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Sino Biological Recent Developments/Updates
7.14.6 Sino Biological Competitive Strengths & Weaknesses
7.15 Biomatik
7.15.1 Biomatik Details
7.15.2 Biomatik Major Business
7.15.3 Biomatik CD98 Antibody Product and Services
7.15.4 Biomatik CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Biomatik Recent Developments/Updates
7.15.6 Biomatik Competitive Strengths & Weaknesses
7.16 CUSABIO Technology
7.16.1 CUSABIO Technology Details
7.16.2 CUSABIO Technology Major Business
7.16.3 CUSABIO Technology CD98 Antibody Product and Services
7.16.4 CUSABIO Technology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 CUSABIO Technology Recent Developments/Updates
7.16.6 CUSABIO Technology Competitive Strengths & Weaknesses
7.17 Affinity Biosciences
7.17.1 Affinity Biosciences Details
7.17.2 Affinity Biosciences Major Business
7.17.3 Affinity Biosciences CD98 Antibody Product and Services
7.17.4 Affinity Biosciences CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Affinity Biosciences Recent Developments/Updates
7.17.6 Affinity Biosciences Competitive Strengths & Weaknesses
7.18 Creative Biolabs
7.18.1 Creative Biolabs Details
7.18.2 Creative Biolabs Major Business
7.18.3 Creative Biolabs CD98 Antibody Product and Services
7.18.4 Creative Biolabs CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Creative Biolabs Recent Developments/Updates
7.18.6 Creative Biolabs Competitive Strengths & Weaknesses
7.19 Jingjie PTM BioLab
7.19.1 Jingjie PTM BioLab Details
7.19.2 Jingjie PTM BioLab Major Business
7.19.3 Jingjie PTM BioLab CD98 Antibody Product and Services
7.19.4 Jingjie PTM BioLab CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Jingjie PTM BioLab Recent Developments/Updates
7.19.6 Jingjie PTM BioLab Competitive Strengths & Weaknesses
7.20 Beijing Solarbio
7.20.1 Beijing Solarbio Details
7.20.2 Beijing Solarbio Major Business
7.20.3 Beijing Solarbio CD98 Antibody Product and Services
7.20.4 Beijing Solarbio CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Beijing Solarbio Recent Developments/Updates
7.20.6 Beijing Solarbio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CD98 Antibody Industry Chain
8.2 CD98 Antibody Upstream Analysis
8.3 CD98 Antibody Midstream Analysis
8.4 CD98 Antibody Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World CD98 Antibody Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World CD98 Antibody Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World CD98 Antibody Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World CD98 Antibody Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World CD98 Antibody Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CD98 Antibody Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World CD98 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World CD98 Antibody Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World CD98 Antibody Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key CD98 Antibody Players in 2022
Table 12. World CD98 Antibody Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global CD98 Antibody Company Evaluation Quadrant
Table 14. Head Office of Key CD98 Antibody Player
Table 15. CD98 Antibody Market: Company Product Type Footprint
Table 16. CD98 Antibody Market: Company Product Application Footprint
Table 17. CD98 Antibody Mergers & Acquisitions Activity
Table 18. United States VS China CD98 Antibody Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China CD98 Antibody Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based CD98 Antibody Companies, Headquarters (States, Country)
Table 21. United States Based Companies CD98 Antibody Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies CD98 Antibody Revenue Market Share (2018-2023)
Table 23. China Based CD98 Antibody Companies, Headquarters (Province, Country)
Table 24. China Based Companies CD98 Antibody Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies CD98 Antibody Revenue Market Share (2018-2023)
Table 26. Rest of World Based CD98 Antibody Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CD98 Antibody Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies CD98 Antibody Revenue Market Share (2018-2023)
Table 29. World CD98 Antibody Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World CD98 Antibody Market Size by Type (2018-2023) & (USD Million)
Table 31. World CD98 Antibody Market Size by Type (2024-2029) & (USD Million)
Table 32. World CD98 Antibody Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World CD98 Antibody Market Size by Application (2018-2023) & (USD Million)
Table 34. World CD98 Antibody Market Size by Application (2024-2029) & (USD Million)
Table 35. Merck Basic Information, Area Served and Competitors
Table 36. Merck Major Business
Table 37. Merck CD98 Antibody Product and Services
Table 38. Merck CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Merck Recent Developments/Updates
Table 40. Merck Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific CD98 Antibody Product and Services
Table 44. Thermo Fisher Scientific CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Bioss Basic Information, Area Served and Competitors
Table 48. Bioss Major Business
Table 49. Bioss CD98 Antibody Product and Services
Table 50. Bioss CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bioss Recent Developments/Updates
Table 52. Bioss Competitive Strengths & Weaknesses
Table 53. Proteintech Group Basic Information, Area Served and Competitors
Table 54. Proteintech Group Major Business
Table 55. Proteintech Group CD98 Antibody Product and Services
Table 56. Proteintech Group CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Proteintech Group Recent Developments/Updates
Table 58. Proteintech Group Competitive Strengths & Weaknesses
Table 59. Aviva Systems Biology Basic Information, Area Served and Competitors
Table 60. Aviva Systems Biology Major Business
Table 61. Aviva Systems Biology CD98 Antibody Product and Services
Table 62. Aviva Systems Biology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Aviva Systems Biology Recent Developments/Updates
Table 64. Aviva Systems Biology Competitive Strengths & Weaknesses
Table 65. Leading Biology Basic Information, Area Served and Competitors
Table 66. Leading Biology Major Business
Table 67. Leading Biology CD98 Antibody Product and Services
Table 68. Leading Biology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Leading Biology Recent Developments/Updates
Table 70. Leading Biology Competitive Strengths & Weaknesses
Table 71. RayBiotech Basic Information, Area Served and Competitors
Table 72. RayBiotech Major Business
Table 73. RayBiotech CD98 Antibody Product and Services
Table 74. RayBiotech CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. RayBiotech Recent Developments/Updates
Table 76. RayBiotech Competitive Strengths & Weaknesses
Table 77. ABclonal Technology Basic Information, Area Served and Competitors
Table 78. ABclonal Technology Major Business
Table 79. ABclonal Technology CD98 Antibody Product and Services
Table 80. ABclonal Technology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. ABclonal Technology Recent Developments/Updates
Table 82. ABclonal Technology Competitive Strengths & Weaknesses
Table 83. OriGene Technologies Basic Information, Area Served and Competitors
Table 84. OriGene Technologies Major Business
Table 85. OriGene Technologies CD98 Antibody Product and Services
Table 86. OriGene Technologies CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. OriGene Technologies Recent Developments/Updates
Table 88. OriGene Technologies Competitive Strengths & Weaknesses
Table 89. Novus Biologicals Basic Information, Area Served and Competitors
Table 90. Novus Biologicals Major Business
Table 91. Novus Biologicals CD98 Antibody Product and Services
Table 92. Novus Biologicals CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Novus Biologicals Recent Developments/Updates
Table 94. Novus Biologicals Competitive Strengths & Weaknesses
Table 95. R&D Systems Basic Information, Area Served and Competitors
Table 96. R&D Systems Major Business
Table 97. R&D Systems CD98 Antibody Product and Services
Table 98. R&D Systems CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. R&D Systems Recent Developments/Updates
Table 100. R&D Systems Competitive Strengths & Weaknesses
Table 101. AssayPro Basic Information, Area Served and Competitors
Table 102. AssayPro Major Business
Table 103. AssayPro CD98 Antibody Product and Services
Table 104. AssayPro CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. AssayPro Recent Developments/Updates
Table 106. AssayPro Competitive Strengths & Weaknesses
Table 107. Abnova Corporation Basic Information, Area Served and Competitors
Table 108. Abnova Corporation Major Business
Table 109. Abnova Corporation CD98 Antibody Product and Services
Table 110. Abnova Corporation CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Abnova Corporation Recent Developments/Updates
Table 112. Abnova Corporation Competitive Strengths & Weaknesses
Table 113. Sino Biological Basic Information, Area Served and Competitors
Table 114. Sino Biological Major Business
Table 115. Sino Biological CD98 Antibody Product and Services
Table 116. Sino Biological CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Sino Biological Recent Developments/Updates
Table 118. Sino Biological Competitive Strengths & Weaknesses
Table 119. Biomatik Basic Information, Area Served and Competitors
Table 120. Biomatik Major Business
Table 121. Biomatik CD98 Antibody Product and Services
Table 122. Biomatik CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Biomatik Recent Developments/Updates
Table 124. Biomatik Competitive Strengths & Weaknesses
Table 125. CUSABIO Technology Basic Information, Area Served and Competitors
Table 126. CUSABIO Technology Major Business
Table 127. CUSABIO Technology CD98 Antibody Product and Services
Table 128. CUSABIO Technology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. CUSABIO Technology Recent Developments/Updates
Table 130. CUSABIO Technology Competitive Strengths & Weaknesses
Table 131. Affinity Biosciences Basic Information, Area Served and Competitors
Table 132. Affinity Biosciences Major Business
Table 133. Affinity Biosciences CD98 Antibody Product and Services
Table 134. Affinity Biosciences CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Affinity Biosciences Recent Developments/Updates
Table 136. Affinity Biosciences Competitive Strengths & Weaknesses
Table 137. Creative Biolabs Basic Information, Area Served and Competitors
Table 138. Creative Biolabs Major Business
Table 139. Creative Biolabs CD98 Antibody Product and Services
Table 140. Creative Biolabs CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Creative Biolabs Recent Developments/Updates
Table 142. Creative Biolabs Competitive Strengths & Weaknesses
Table 143. Jingjie PTM BioLab Basic Information, Area Served and Competitors
Table 144. Jingjie PTM BioLab Major Business
Table 145. Jingjie PTM BioLab CD98 Antibody Product and Services
Table 146. Jingjie PTM BioLab CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Jingjie PTM BioLab Recent Developments/Updates
Table 148. Beijing Solarbio Basic Information, Area Served and Competitors
Table 149. Beijing Solarbio Major Business
Table 150. Beijing Solarbio CD98 Antibody Product and Services
Table 151. Beijing Solarbio CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of CD98 Antibody Upstream (Raw Materials)
Table 153. CD98 Antibody Typical Customers
List of Figure
Figure 1. CD98 Antibody Picture
Figure 2. World CD98 Antibody Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CD98 Antibody Total Market Size (2018-2029) & (USD Million)
Figure 4. World CD98 Antibody Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World CD98 Antibody Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 13. CD98 Antibody Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 16. World CD98 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 17. United States CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 18. China CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 23. India CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of CD98 Antibody by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for CD98 Antibody Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for CD98 Antibody Markets in 2022
Figure 27. United States VS China: CD98 Antibody Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CD98 Antibody Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World CD98 Antibody Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World CD98 Antibody Market Size Market Share by Type in 2022
Figure 31. Monoclonal
Figure 32. Polyclonal
Figure 33. World CD98 Antibody Market Size Market Share by Type (2018-2029)
Figure 34. World CD98 Antibody Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World CD98 Antibody Market Size Market Share by Application in 2022
Figure 36. Immunochemistry (IHC)
Figure 37. Immunofluorescence (IF)
Figure 38. Immunoprecipitation (IP)
Figure 39. Western Blot (WB)
Figure 40. ELISA
Figure 41. Others
Figure 42. CD98 Antibody Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Table 1. World CD98 Antibody Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World CD98 Antibody Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World CD98 Antibody Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World CD98 Antibody Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World CD98 Antibody Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CD98 Antibody Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World CD98 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World CD98 Antibody Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World CD98 Antibody Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key CD98 Antibody Players in 2022
Table 12. World CD98 Antibody Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global CD98 Antibody Company Evaluation Quadrant
Table 14. Head Office of Key CD98 Antibody Player
Table 15. CD98 Antibody Market: Company Product Type Footprint
Table 16. CD98 Antibody Market: Company Product Application Footprint
Table 17. CD98 Antibody Mergers & Acquisitions Activity
Table 18. United States VS China CD98 Antibody Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China CD98 Antibody Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based CD98 Antibody Companies, Headquarters (States, Country)
Table 21. United States Based Companies CD98 Antibody Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies CD98 Antibody Revenue Market Share (2018-2023)
Table 23. China Based CD98 Antibody Companies, Headquarters (Province, Country)
Table 24. China Based Companies CD98 Antibody Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies CD98 Antibody Revenue Market Share (2018-2023)
Table 26. Rest of World Based CD98 Antibody Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CD98 Antibody Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies CD98 Antibody Revenue Market Share (2018-2023)
Table 29. World CD98 Antibody Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World CD98 Antibody Market Size by Type (2018-2023) & (USD Million)
Table 31. World CD98 Antibody Market Size by Type (2024-2029) & (USD Million)
Table 32. World CD98 Antibody Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World CD98 Antibody Market Size by Application (2018-2023) & (USD Million)
Table 34. World CD98 Antibody Market Size by Application (2024-2029) & (USD Million)
Table 35. Merck Basic Information, Area Served and Competitors
Table 36. Merck Major Business
Table 37. Merck CD98 Antibody Product and Services
Table 38. Merck CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Merck Recent Developments/Updates
Table 40. Merck Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific CD98 Antibody Product and Services
Table 44. Thermo Fisher Scientific CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Bioss Basic Information, Area Served and Competitors
Table 48. Bioss Major Business
Table 49. Bioss CD98 Antibody Product and Services
Table 50. Bioss CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bioss Recent Developments/Updates
Table 52. Bioss Competitive Strengths & Weaknesses
Table 53. Proteintech Group Basic Information, Area Served and Competitors
Table 54. Proteintech Group Major Business
Table 55. Proteintech Group CD98 Antibody Product and Services
Table 56. Proteintech Group CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Proteintech Group Recent Developments/Updates
Table 58. Proteintech Group Competitive Strengths & Weaknesses
Table 59. Aviva Systems Biology Basic Information, Area Served and Competitors
Table 60. Aviva Systems Biology Major Business
Table 61. Aviva Systems Biology CD98 Antibody Product and Services
Table 62. Aviva Systems Biology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Aviva Systems Biology Recent Developments/Updates
Table 64. Aviva Systems Biology Competitive Strengths & Weaknesses
Table 65. Leading Biology Basic Information, Area Served and Competitors
Table 66. Leading Biology Major Business
Table 67. Leading Biology CD98 Antibody Product and Services
Table 68. Leading Biology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Leading Biology Recent Developments/Updates
Table 70. Leading Biology Competitive Strengths & Weaknesses
Table 71. RayBiotech Basic Information, Area Served and Competitors
Table 72. RayBiotech Major Business
Table 73. RayBiotech CD98 Antibody Product and Services
Table 74. RayBiotech CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. RayBiotech Recent Developments/Updates
Table 76. RayBiotech Competitive Strengths & Weaknesses
Table 77. ABclonal Technology Basic Information, Area Served and Competitors
Table 78. ABclonal Technology Major Business
Table 79. ABclonal Technology CD98 Antibody Product and Services
Table 80. ABclonal Technology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. ABclonal Technology Recent Developments/Updates
Table 82. ABclonal Technology Competitive Strengths & Weaknesses
Table 83. OriGene Technologies Basic Information, Area Served and Competitors
Table 84. OriGene Technologies Major Business
Table 85. OriGene Technologies CD98 Antibody Product and Services
Table 86. OriGene Technologies CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. OriGene Technologies Recent Developments/Updates
Table 88. OriGene Technologies Competitive Strengths & Weaknesses
Table 89. Novus Biologicals Basic Information, Area Served and Competitors
Table 90. Novus Biologicals Major Business
Table 91. Novus Biologicals CD98 Antibody Product and Services
Table 92. Novus Biologicals CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Novus Biologicals Recent Developments/Updates
Table 94. Novus Biologicals Competitive Strengths & Weaknesses
Table 95. R&D Systems Basic Information, Area Served and Competitors
Table 96. R&D Systems Major Business
Table 97. R&D Systems CD98 Antibody Product and Services
Table 98. R&D Systems CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. R&D Systems Recent Developments/Updates
Table 100. R&D Systems Competitive Strengths & Weaknesses
Table 101. AssayPro Basic Information, Area Served and Competitors
Table 102. AssayPro Major Business
Table 103. AssayPro CD98 Antibody Product and Services
Table 104. AssayPro CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. AssayPro Recent Developments/Updates
Table 106. AssayPro Competitive Strengths & Weaknesses
Table 107. Abnova Corporation Basic Information, Area Served and Competitors
Table 108. Abnova Corporation Major Business
Table 109. Abnova Corporation CD98 Antibody Product and Services
Table 110. Abnova Corporation CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Abnova Corporation Recent Developments/Updates
Table 112. Abnova Corporation Competitive Strengths & Weaknesses
Table 113. Sino Biological Basic Information, Area Served and Competitors
Table 114. Sino Biological Major Business
Table 115. Sino Biological CD98 Antibody Product and Services
Table 116. Sino Biological CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Sino Biological Recent Developments/Updates
Table 118. Sino Biological Competitive Strengths & Weaknesses
Table 119. Biomatik Basic Information, Area Served and Competitors
Table 120. Biomatik Major Business
Table 121. Biomatik CD98 Antibody Product and Services
Table 122. Biomatik CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Biomatik Recent Developments/Updates
Table 124. Biomatik Competitive Strengths & Weaknesses
Table 125. CUSABIO Technology Basic Information, Area Served and Competitors
Table 126. CUSABIO Technology Major Business
Table 127. CUSABIO Technology CD98 Antibody Product and Services
Table 128. CUSABIO Technology CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. CUSABIO Technology Recent Developments/Updates
Table 130. CUSABIO Technology Competitive Strengths & Weaknesses
Table 131. Affinity Biosciences Basic Information, Area Served and Competitors
Table 132. Affinity Biosciences Major Business
Table 133. Affinity Biosciences CD98 Antibody Product and Services
Table 134. Affinity Biosciences CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Affinity Biosciences Recent Developments/Updates
Table 136. Affinity Biosciences Competitive Strengths & Weaknesses
Table 137. Creative Biolabs Basic Information, Area Served and Competitors
Table 138. Creative Biolabs Major Business
Table 139. Creative Biolabs CD98 Antibody Product and Services
Table 140. Creative Biolabs CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Creative Biolabs Recent Developments/Updates
Table 142. Creative Biolabs Competitive Strengths & Weaknesses
Table 143. Jingjie PTM BioLab Basic Information, Area Served and Competitors
Table 144. Jingjie PTM BioLab Major Business
Table 145. Jingjie PTM BioLab CD98 Antibody Product and Services
Table 146. Jingjie PTM BioLab CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Jingjie PTM BioLab Recent Developments/Updates
Table 148. Beijing Solarbio Basic Information, Area Served and Competitors
Table 149. Beijing Solarbio Major Business
Table 150. Beijing Solarbio CD98 Antibody Product and Services
Table 151. Beijing Solarbio CD98 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of CD98 Antibody Upstream (Raw Materials)
Table 153. CD98 Antibody Typical Customers
List of Figure
Figure 1. CD98 Antibody Picture
Figure 2. World CD98 Antibody Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CD98 Antibody Total Market Size (2018-2029) & (USD Million)
Figure 4. World CD98 Antibody Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World CD98 Antibody Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company CD98 Antibody Revenue (2018-2029) & (USD Million)
Figure 13. CD98 Antibody Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 16. World CD98 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 17. United States CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 18. China CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 23. India CD98 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of CD98 Antibody by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for CD98 Antibody Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for CD98 Antibody Markets in 2022
Figure 27. United States VS China: CD98 Antibody Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CD98 Antibody Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World CD98 Antibody Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World CD98 Antibody Market Size Market Share by Type in 2022
Figure 31. Monoclonal
Figure 32. Polyclonal
Figure 33. World CD98 Antibody Market Size Market Share by Type (2018-2029)
Figure 34. World CD98 Antibody Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World CD98 Antibody Market Size Market Share by Application in 2022
Figure 36. Immunochemistry (IHC)
Figure 37. Immunofluorescence (IF)
Figure 38. Immunoprecipitation (IP)
Figure 39. Western Blot (WB)
Figure 40. ELISA
Figure 41. Others
Figure 42. CD98 Antibody Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
